Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review.

Journal of the American Geriatrics Society
Michele L RiesSterling C Johnson

Abstract

Given the predicted increase in prevalence of Alzheimer's disease (AD) in the coming decades, early detection and intervention in persons with the predementia condition known as mild cognitive impairment (MCI) is of paramount importance. Recent years have seen remarkable advances in the application of neuroimaging and other biomarkers to the study of MCI. This article reviews the most recent developments in the use of magnetic resonance imaging (MRI) to characterize brain changes and to prognosticate clinical outcomes of patients with MCI. The review begins with description of methods and findings in structural MRI research, delineating findings regarding both gross atrophy and microstructural brain changes in MCI. Second, we describe the most recent findings regarding brain function in MCI, enumerating findings from functional MRI and brain perfusion studies. Third, we will make recommendations regarding the current clinical use of MRI in identification of MCI. As a conclusion, we will look to the future of neuroimaging as a tool in early AD detection.

References

Jan 1, 1993·European Neurology·H BraakJ Bohl
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·B A StrangeR J Dolan
Jul 11, 2001·Neurobiology of Aging·S De SantiJ Fowler
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·A T DuM W Weiner
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kooresh Shoghi-JadidJorge R Barrio
Apr 24, 2002·Neurology·R J KillianyM S Albert
Jul 4, 2002·International Psychogeriatrics·Cássio M C BottinoMário R Louzã Neto
Jul 24, 2002·Brain : a Journal of Neurology·Sterling C JohnsonGeorge P Prigatano
Oct 24, 2002·Neuroreport·Gaël ChételatJean-Claude Baron
Nov 2, 2002·Dementia and Geriatric Cognitive Disorders·Kejal KantarciClifford R Jack
Feb 27, 2003·Acta Neurologica Scandinavica. Supplementum·Katie PalmerBengt Winblad
Jun 25, 2003·Brain : a Journal of Neurology·Gaël ChetelatFrancis Eustache
Aug 20, 2003·Archives of Neurology·Liesi E HebertDenis A Evans
Nov 5, 2003·Nature Reviews. Neuroscience·Mark D'EspositoAdam Gazzaley
Jan 21, 2004·Archives of Neurology·Michael GrundmanUNKNOWN Alzheimer's Disease Cooperative Study
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
Mar 5, 2004·Neuropsychologia·Sterling C JohnsonRichard J Caselli
Mar 12, 2004·Journal of the International Neuropsychological Society : JINS·Natalie A PhillipsSusan Murtha
Apr 17, 2004·Dementia and Geriatric Cognitive Disorders·Andreas FellgiebelPeter Stoeter
May 5, 2004·Neurobiology of Aging·Corina PennanenHilkka Soininen
Jun 24, 2004·Neurobiology of Aging·Henrike WolfHermann-Josef Gertz
Jul 6, 2004·Annals of Neurology·Bradford C DickersonReisa A Sperling
Jul 14, 2004·Neurology·Mary GanguliSteven T DeKosky
Aug 18, 2004·Neurobiology of Aging·Leyla deToledo-MorrellD A Turner
Aug 25, 2004·Journal of Internal Medicine·M J de LeonH Rusinek
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Benjamin J Shannon, Randy L Buckner
Dec 21, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·C PennanenH Soininen
May 11, 2005·Neurology·T R StoubL deToledo-Morrell
Jun 18, 2005·NeuroImage·Serge A R B RomboutsPhilip Scheltens
Aug 9, 2005·NeuroImage·Matthias J MüllerAndreas Fellgiebel
Aug 17, 2005·NeuroImage·Michele L RiesSterling C Johnson
Jan 13, 2006·Archives of Neurology·James T BeckerUNKNOWN Imaging Methods and Analysis in Geriatrics Research Group

❮ Previous
Next ❯

Citations

Jan 19, 2010·Annals of Nuclear Medicine·Alexander Drzezga
Aug 21, 2009·International Psychogeriatrics·Lena EhrekeSteffi G Riedel-Heller
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Jan 31, 2013·Seminars in Neurology·Daniel A OrringerAlexandra J Golby
May 15, 2009·Brain : a Journal of Neurology·Yu ZhangMichael W Weiner
Dec 12, 2012·Epidemiologic Reviews·Esmée L DoetsLisette C P G M de Groot
Jan 2, 2013·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Marian van der MeulenFrédéric Assal
Jan 2, 2013·Dementia and Geriatric Cognitive Disorders Extra·Jean-François MorinCarol Hudon
Dec 2, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Deepti PutchaReisa Sperling
Sep 26, 2014·International Journal of Alzheimer's Disease·Simon DuchesneNicolas Robitaille
May 7, 2013·The Medical Clinics of North America·Stefan J TeipelHarald Hampel
Jan 24, 2009·Journal of the Neurological Sciences·Feng BaiJianping Jia
Feb 20, 2009·Journal of Neurochemistry·Paul W ThompsonAndrew Lockhart
Sep 22, 2015·International Journal of Geriatric Psychiatry·Kazuki UemuraTakao Suzuki
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Yakeel T QuirozChantal E Stern
May 18, 2010·Neurobiology of Aging·Carrie R McDonaldUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 17, 2009·Neurobiology of Aging·Luiz K FerreiraMarcus V Zanetti
Apr 1, 2014·Brain Structure & Function·Gabriel Gonzalez-EscamillaJose L Cantero
Jul 26, 2011·Neurobiology of Aging·Manuela TondelliGiovanna Zamboni
Aug 29, 2014·Frontiers in Aging Neuroscience·N ChechkoU Habel
Jan 26, 2011·Journal of Clinical Neurology·Seon-Young RyuAe Young Lee
Sep 29, 2015·Journal of the International Neuropsychological Society : JINS·Lisa QuenonAdrian Ivanoiu
Jun 1, 2017·Journal of Neuroengineering and Rehabilitation·Hiroyuki ShimadaMegumi Suzukawa
May 22, 2018·Journal of Alzheimer's Disease : JAD·Ellis NiemantsverdrietSebastiaan Engelborghs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.